# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 111-120 of 2722 results.
Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian Cancer
Status: Completed
Last Changed: Oct 20, 2020
First Received: Jan 15, 2013
Disease(s): Metastatic Ovarian Cancer
Intervention(s): Experimental arm
Locations: Institut Bergonié, Bordeaux, France
CRLC Val d'Aurelle-Paul Lamarque, Montpellier, France
Niraparib Maintenance in Patients With Advanced Ovarian Cancer at Neoadjuvant Setting
Status: Recruiting
Last Changed: Sep 16, 2020
First Received: Feb 26, 2020
Disease(s): Ovarian Cancer
Intervention(s): Niraparib
Locations: The University of Hong Kong, Hong Kong, Hong Kong
Clinical Impact of Dedicated MR Staging of Ovarian Cancer
Status: Recruiting
Last Changed: May 22, 2018
First Received: Jan 16, 2018
Disease(s): Ovarian Cancer
Intervention(s): MRI
Locations: NKI-AVL, Amsterdam, Netherlands
Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy
Status: Completed
Last Changed: Apr 11, 2006
First Received: Apr 11, 2006
Disease(s): Ovarian Cancer
Intervention(s): Hycamtin, Gemcitabine
Locations: Charité Campus Virchow-Klinikum, Berlin, Germany
Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status
Status: Completed
Last Changed: Jun 10, 2015
First Received: Sep 24, 2012
Disease(s): Ovarian Cancer
Intervention(s): Veliparib, Topotecan
Locations: Department of Oncology, Vejle Hospital, Vejle, Denmark
C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer Population
Status: Active, not recruiting
Last Changed: Oct 08, 2020
First Received: Jul 21, 2015
Disease(s): Ovarian Cancer, Hereditary Ovarian Cancer Syndrome
Locations: Research Site, Amberg, Germany
Research Site, Aschaffenburg, Germany
Research Site, Augsburg, Germany
Research Site, Bad Homburg, Germany
Research Site, Berlin, Germany
... and 64 other locations.
WISER After Ovarian Cancer - Exercise Pilot Study
Status: Completed
Last Changed: Apr 16, 2020
First Received: Aug 20, 2015
Disease(s): Ovarian Cancer
Intervention(s): Exercise
Locations: Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian Cancer
Status: Completed
Last Changed: May 09, 2019
First Received: Dec 01, 2014
Disease(s): Recurrent Ovarian Cancer
Intervention(s): Nuc-1031 and Carboplatin
Locations: Garry Weston Cancer Centre, Hammersmith Hospital, London, United Kingdom
A Study of Apatinib Treatment in for Advanced Ovarian Cancer
Status: Unknown status
Last Changed: Jan 16, 2018
First Received: Jan 08, 2018
Disease(s): Ovarian Cancer, Chemotherapeutic Toxicity
Intervention(s): Apatinib, Taxus + platinum
Locations: Zhang xuan, Leshan, Sichuan, China
Prognostic and Predictive Biomarkers in Ovarian Cancers
Status: Recruiting
Last Changed: Feb 17, 2020
First Received: Jan 04, 2017
Disease(s): Ovarian Cancer
Intervention(s): Blood sample
Locations: Gustave Roussy, Villejuif, Val De Marne, France